Page 311 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 311

290   PART III    Therapeutic Modalities for the Cancer Patient



          TABLE 16.2     Behaviors That May Be Seen with Cancer   Quantitative Sensory Testing
                      and Cancer Therapy–Associated Pain in    Objective methods to measure central sensitization secondary to
  VetBooks.ir  Behavior  Cats and Dogs                         chronic pain recently have been developed in veterinary medicine.
                             Notes
                                                               Quantitative sensory testing (QST) consists of the measurement
            Activity         Decreased activity and diminished engage-  of evoked responses to mechanical and thermal stimuli through
                              ment in the activities of daily living (playing);   the use of various devices. Feasibility and repeatability studies of
                              altered gait or lameness can be associated   these modalities have being performed in normal and osteoar-
                              with generalized pain but is more often   thritic dogs. 76,77  Currently, published QST studies in dogs or cats
                              associated with limb or joint pain; quality    with cancer pain exist, although the authors (MN, BDXL) have
                              of sleep may be adversely affected, mani-  used QST to assess sensitivity associated with RT. The use of QST
                              festing as increased restlessness or altered   and related testing modalities has significant potential to help us
                              sleep-wake cycles.               understand the pathophysiology of cancer pain and potentially in
            Appetite         Often diminished with chronic cancer pain.  the “cage-side” diagnosis of cancer pain–related abnormalities in
                                                               sensory processing. 
            Attitude         Any change in behavior can be associated
                              with cancer pain—aggressiveness, dullness,
                              shyness, ‘clinging,’ increased dependence.  Drugs and Strategies Used for Management
            Facial expression  Head hung low and squinted eyes in cats. Sad   of Pain in Cancer Patients
                              expression in dogs, head carried low.
            Grooming         Failure to groom can result from a painful oral   The drugs that can be used for chronic cancer pain management are
                              lesion or generalized pain.      listed in Tables 16.4 and 16.5. The following discussions are not a
                                                               comprehensive appraisal of each class of drug, but rather are sugges-
            Response to palpation  (One of the best ways to diagnose and monitor   tions for their use for cancer pain. Fig. 16.1 presents an assessment
                              pain.) Pain can be elicited by palpation of   and treatment scheme to help the reader easily devise a strategic
                              the affected area, or manipulation of the
                              affected area, which exacerbates the pain   plan to manage pain in cancer patients. If pain scores improve after
                              present. This is manifested as an aversion   the initial base treatment, an analgesic ladder or a reverse pyramid
                              response from the animal (i.e., the animal   approach can be applied (i.e., the number and dosages of drugs
                              attempts to escape the procedure, or yowls,   administered can be reduced). If pain persist, a more aggressive and
                              cries, hisses, or bites).        multimodal analgesic strategy must be implemented. The adjunc-
                                                               tive drugs listed in this scheme can be used on their own, or poten-
            Respiration      May be elevated with severe cancer pain.
                                                               tially two “base” analgesics could be combined (e.g., an NSAID
            Self-traumatization  Licking at an area (bone with primary bone   and acetaminophen). However, the way this influences the side
                              cancer, the abdomen with intraabdominal   effects likely to be seen is unknown, except in the case of NSAIDs
                              cancer) can indicate pain. Scratching can   plus steroids, a combination known to increase the risk of serious
                              indicate pain (e.g., scratching at cutaneous   adverse events (gastrointestinal ulceration). Euthanasia should be
                              tumors, scratching and biting at the flank   considered  only  when pain  persists  and  significantly  affects the
                              with prostatic or colonic neoplasia).
                                                               patient’s QOL or when the necessary analgesic relief caused unac-
            Urinary and bowel   Failure to use litter box (cats); urinating and   ceptable side effects (e.g., moribund, unresponsive, comatose).
              elimination     defecating inside (dogs).
            Vocalization     Vocalization is rare in response to cancer pain   Nonsteroidal Antiinflammatory Drugs
                              in dogs and cats; however, owners of dogs
                              often report frequent odd noises (whin-  NSAIDs are commonly the first line of treatment in cancer pain.
                              ing, grunting) associated with cancer pain.   Several excellent reviews on NSAID use in small animals have
                              Occasionally cats will hiss, utter spontane-  been published, and the reader is referred to these. 72,78–82  The
                              ous plaintive meows, or purr in association   choice of available NSAIDs can be bewildering, but a few key
                              with cancer pain.                points should be kept in mind.
                                                                •   On a population basis, all NSAIDs are probably equally effica-

                                                                  cious in relieving pain; however, for a given patient, one drug
                                                                  often is more effective than another.
         did not uncover any effects of osteoarthritis pain. Recent work    •   Gastrointestinal side effects associated with NSAID use appear
         has extended our understanding of factors affecting accelerometer   to be more common with drugs that preferentially block
                      74
         output in dogs.  Accelerometry is performed in client-owned   COX-1 over COX-2.
         animals, in their home environments, with the accelerometers    •   No difference in renal toxicity is seen between COX-1 selective
         mounted on collars. Human chronic cancer patients with pain   drugs and COX-2 selective drugs.
         are more likely to present with sedentary behavioral patterns and    •   Liver toxicity can occur with any NSAID.
         fatigue.  Similar studies have not been performed in small ani-   •   No NSAID is completely safe, but the approved NSAIDs are
               75
         mals with cancer, but accelerometry and activity measures hold   significantly safer than the older, nonapproved NSAIDs.
         promise as a tool to assess pain and cancer-related changes in    •   Longer term or continuous NSAID use appears to be more
                                                                                                 80
         activity. Approximately 10 activity monitors are marketed specifi-  effective than short-term or reactive use ; however, when the
         cally for small animals, although current understanding of what   disease is relatively stable, gradual dose reduction may be pos-
         the output of each activity monitor actually relates to is limited.   sible while maintaining efficacy. 69
   306   307   308   309   310   311   312   313   314   315   316